In-vitro and in-silico analysis and antitumor studies of novel Cu(II) and V(V) complexes of N-p-Tolylbenzohydroxamic acid

Int J Biol Macromol. 2024 May;268(Pt 1):131768. doi: 10.1016/j.ijbiomac.2024.131768. Epub 2024 Apr 24.

Abstract

Copper(L2Cu) and vanadium(L2VOCl) complexes of N-p-tolylbenzohydroxamic acid (LH) ligand have been investigated for DNA binding efficacy by multiple analytical, spectral, and computational techniques. The results revealed that complexes as groove binders as evidenced by UV absorption. Fluorescence studies including displacement assay using classical intercalator ethidium bromide as fluorescent probe also confirmed as groove binders. The viscometric analysis too supports the inferences as strong groove binders for both the complexes. Molecular docking too exposed DNA as a target to the complexes which precisely binds L2Cu, in the minor groove region while L2VOCl in major groove region. Molecular dynamic simulation performed on L2Cu complex revealing the interaction of complex with DNA within 20 ns time. The complex stacked into the nitrogen bases of oligonucleotides and the bonding features were intrinsically preserved for longer simulation times. In-vitro cytotoxicity study was undertaken employing MTT assay against the breast cancer cell line (MCF-7). Potential cytotoxic activities were observed for L2Cu and L2VOCl complexes with IC50 values of showing 71 % and 74 % of inhibition respectively.

Keywords: Computational analysis; Fluorescence studies; In vitro cytotoxic activity; Metal complexes.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Coordination Complexes / chemistry
  • Coordination Complexes / pharmacology
  • Copper* / chemistry
  • DNA* / chemistry
  • DNA* / metabolism
  • Humans
  • Hydroxamic Acids* / chemistry
  • Hydroxamic Acids* / pharmacology
  • Ligands
  • MCF-7 Cells
  • Molecular Docking Simulation*
  • Molecular Dynamics Simulation
  • Vanadium* / chemistry
  • Vanadium* / pharmacology